576 related articles for article (PubMed ID: 31303349)
1. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
[TBL] [Abstract][Full Text] [Related]
2. Acute declines in estimated glomerular filtration rate on enalapril and mortality and cardiovascular outcomes in patients with heart failure with reduced ejection fraction.
McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
Kidney Int; 2019 Nov; 96(5):1185-1194. PubMed ID: 31420191
[TBL] [Abstract][Full Text] [Related]
3. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Ishigami J; Kansal M; Mehta R; Srivastava A; Rahman M; Dobre M; Al-Kindi SG; Go AS; Navaneethan SD; Chen J; He J; Bhat ZY; Jaar BG; Appel LJ; Matsushita K;
Am J Kidney Dis; 2023 Aug; 82(2):225-236. PubMed ID: 36935072
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
[TBL] [Abstract][Full Text] [Related]
6. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
[TBL] [Abstract][Full Text] [Related]
7. Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial.
Bowling CB; Sanders PW; Allman RM; Rogers WJ; Patel K; Aban IB; Rich MW; Pitt B; White M; Bakris GC; Fonarow GC; Ahmed A
Int J Cardiol; 2013 Jul; 167(1):151-6. PubMed ID: 22257685
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.
Xu X; Qin X; Li Y; Sun D; Wang J; Liang M; Wang B; Huo Y; Hou FF;
JAMA Intern Med; 2016 Oct; 176(10):1443-1450. PubMed ID: 27548766
[TBL] [Abstract][Full Text] [Related]
9. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
11. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
Beldhuis IE; Streng KW; Ter Maaten JM; Voors AA; van der Meer P; Rossignol P; McMurray JJ; Damman K
Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209765
[TBL] [Abstract][Full Text] [Related]
12. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
[TBL] [Abstract][Full Text] [Related]
13. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
[TBL] [Abstract][Full Text] [Related]
14. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
Kimura K; Hosoya T; Uchida S; Inaba M; Makino H; Maruyama S; Ito S; Yamamoto T; Tomino Y; Ohno I; Shibagaki Y; Iimuro S; Imai N; Kuwabara M; Hayakawa H; Ohtsu H; Ohashi Y;
Am J Kidney Dis; 2018 Dec; 72(6):798-810. PubMed ID: 30177485
[TBL] [Abstract][Full Text] [Related]
15. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.
Zelnick LR; Katz R; Young BA; Correa A; Kestenbaum BR; de Boer IH; Bansal N
Am J Kidney Dis; 2017 Aug; 70(2):199-206. PubMed ID: 28143672
[TBL] [Abstract][Full Text] [Related]
17. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
Lam PH; Dooley DJ; Fonarow GC; Butler J; Bhatt DL; Filippatos GS; Deedwania P; Forman DE; White M; Fletcher RD; Arundel C; Blackman MR; Adamopoulos C; Kanonidis IE; Aban IB; Patel K; Aronow WS; Allman RM; Anker SD; Pitt B; Ahmed A
Eur J Heart Fail; 2018 Feb; 20(2):359-369. PubMed ID: 28980368
[TBL] [Abstract][Full Text] [Related]
18. Effect of Vitamin B
Li Y; Spence JD; Wang X; Huo Y; Xu X; Qin X
Am J Kidney Dis; 2020 Mar; 75(3):325-332. PubMed ID: 31629573
[TBL] [Abstract][Full Text] [Related]
19. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
20. Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.
Xie Y; Bowe B; Xian H; Balasubramanian S; Al-Aly Z
Am J Kidney Dis; 2016 Aug; 68(2):219-228. PubMed ID: 26948835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
